Results 121 to 130 of about 3,372 (158)

Modulation of L-Type Calcium Currents by Resveratrol-Induced Myogenesis in C2C12 Cells. [PDF]

Cells
Biagini A, Sallicandro L, Covarelli J, Gentile R, Mirarchi A, Farinelli A, Reali G, Del Bianco D, Quellari PT, Gliozheni E, Malvasi A, Baldini GM, Trojano G, Tubaro C, Bearzi C, Rizzi R, Arcuri C, Prontera P, Tinelli A, Fioretti B.   +19 more
europepmc   +1 more source

Intraoperative Neuromuscular Monitoring: Electromyography Monitor Versus Peripheral Nerve Stimulator. Does the Face Lie? [PDF]

J Med Cases
Villalobos EE, Paredes Padilla S, Brull SJ, Tobias JD.   +3 more
europepmc   +1 more source

Interactions between Org9426 and other non-depolarizing neuromuscular blocking agents in rats in vivo

, 1993
openaire   +1 more source

Disposition and effects of some non-depolarizing neuromuscular blocking agents in animal and man

, 1976
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Depolarizing Neuromuscular Blocking Agents

2017
Succinylcholine was first introduced into clinical practice in the 1950s, and is currently the only depolarizing neuromuscular blocker in use. It is unique among the drugs used for muscle relaxation in its rapid onset and short duration of action. These characteristics account for its extensive use in scenarios requiring emergency control of the airway.
Caroline S. Gross, Zhiling Xiong
exaly   +2 more sources

Increased Sensitivity to Depolarizing and Nondepolarizing Neuromuscular Blocking Agents in Young Rat Hemidiaphragms

Anesthesiology, 2001
Background Newborn neuromuscular junctions are more sensitive to d-tubocurarine than more mature preparations. It is unclear whether the same modifications occur with newer nondepolarizing agents and depolarizing agent succinylcholine.
Richard Robitaille, F Donati, Donati François   +2 more
exaly   +3 more sources

Interactions between ORG9426 and other non-depolarizing neuromuscular blocking agents in ratsin vivo

Journal of Anesthesia, 1992
In this study, combined neuromuscular blocking effects of ORG9426 with other non-depolarizing neuromuscular blocking agents were investigated. About 20% steady state neuromuscular block was established by a continuous infusion of one of 6 neuromuscular blocking agents (ORG9426, vecuronium, pancuronium, pipecuronium, d-tubocurarine and metocurine). Then
Kazuhiko Watanabe
exaly   +3 more sources

A study in vitro of new short-acting, non-depolarizing neuromuscular blocking agents

Biochemical Pharmacology, 1969
Abstract Presently available short-acting, depolarizing myoneural blocking agents have significant side effects such as increased intraocular tension, cardiac arrhythmias desensitization of the postjunctional membrane, skeletal muscle injury and muscle pains. Non-depolarizing blocking drugs do not produce profound blocks of short duration.
S Ginsburg, R J Kitz
exaly   +3 more sources

DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND INTRAOCULAR PRESSURE IN VIVO

Anesthesiology, 1957
J B Dillon, D B Taylor, Dillon John B
exaly   +3 more sources

THE MECHANISMS UNDERLYING NEUROMUSCULAR BLOCK FOLLOWING PROLONGED EXPOSURE TO DEPOLARIZING AGENTS

Annals of the New York Academy of Sciences, 1966
A J, Gissen, W L, Nastuk
exaly   +3 more sources